Grifols SA, European major player in blood plasma products acquires Talecris Biotherapeutics for USD 3 B to expand its share in the US market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: PharmaDeals Ltd